4.5 Article

Systematic expression analysis of genes related to multidrug-resistance in isogenic docetaxel- and adriamycin-resistant breast cancer cell lines

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Two different docetaxel resistant MCF-7 sublines exhibited different gene expression pattern

Ozlem Darcansoy Iseri et al.

MOLECULAR BIOLOGY REPORTS (2012)

Article Oncology

The role of the miR-200 family in epithelial-mesenchymal transition

Perry S. Mongroo et al.

CANCER BIOLOGY & THERAPY (2010)

Article Oncology

Chemotherapy resistance in metastatic breast cancer: the evolving role of ixabepilone

Edgardo Rivera et al.

BREAST CANCER RESEARCH (2010)

Review Pharmacology & Pharmacy

Paclitaxel and docetaxel in the treatment of breast cancer

Emmanouel Saloustros et al.

EXPERT OPINION ON PHARMACOTHERAPY (2008)

Review Biochemistry & Molecular Biology

The Bcl-2 apoptotic switch in cancer development and therapy

J. M. Adams et al.

ONCOGENE (2007)

Article Biochemistry & Molecular Biology

Bcl-2 and Bcl-xL are important for the induction of paclitaxel resistance in human hepatocellular carcinoma cells

EY Chun et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)

Review Biochemistry & Molecular Biology

The role of glutathione-S-transferase in anti-cancer drug resistance

DM Townsend et al.

ONCOGENE (2003)

Article Oncology

Prediction of response to docetaxel by CYP3A4 mRNA expression in breast cancer tissues

Y Miyoshi et al.

INTERNATIONAL JOURNAL OF CANCER (2002)

Review Oncology

A family of drug transporters: The multidrug resistance-associated proteins

P Borst et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)